The sale is small and routine; no immediate read-through. Monitor for any larger insider sales or changes in insider sentiment in future filings.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $93.54entry
- T+1 · 11d ago +0.19%α −0.12% · $93.72
- T+5 · 5d ago −0.22%α −3.52% · $93.33
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Christopher Peetz, an officer and director of Mirum Pharmaceuticals, filed a Form 144 notice of intent to sell 20,000 shares of common stock with an approximate market value of $1.8 million. The shares were acquired via a stock option exercise on the same day. This is a relatively small sale relative to the company's $5.6B market cap and Peetz's total holdings, and the filing is routine for insider liquidity.
Key Facts
- Insider: Christopher Peetz (Officer and Director)
- Shares to be sold: 20,000 shares of common stock
- Estimated value: $1,800,000 (based on $90.00 per share)
- Acquisition: Stock option exercise on 11/04/2026 (same day as filing)
- Broker: Morgan Stanley Smith Barney LLC
- Prior sales in last 3 months: 30,000 shares on 09/01/2026 and 20,000 shares on 08/10/2026
- Company market cap: $5.6B
Financial Impact
Sale of 20,000 shares valued at ~$1.8M, representing ~0.03% of market cap
Risk Factors
- Insider selling may signal reduced conviction, though this sale is small relative to holdings and market cap
- Form 144 is an intent to sell; the sale may not be executed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010687 |
| Document: 0001950047-26-010687-index.html | 0001950047-26-010687 |
| Document: 0001950047-26-010687.txt | 0001950047-26-010687 |
Track record
27 reports on MIRM
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers